Share Capital and Other Equity Instruments (Tables)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2021 |
Dec. 31, 2020 |
| Schedule of Stock Options |
| |
|
Number of Shares |
|
|
Weighted Average Exercise Price (USD) |
|
|
Weighted Average Grant Date Fair Value (USD) |
|
|
Weighted Average Remaining Contractual Term (years) |
|
|
Aggregate Intrinsic Value (USD) |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding – January 1, 2021 |
|
|
929,765 |
|
|
$ |
1.53 |
|
|
$ |
2.50 |
|
|
|
|
|
|
|
|
|
| Expired forfeited, or cancelled |
|
|
(560,404 |
) |
|
$ |
1.65 |
|
|
$ |
1.66 |
|
|
|
|
|
|
|
|
|
| Outstanding – December 31, 2020 |
|
|
369,361 |
|
|
$ |
1.35 |
|
|
$ |
3.80 |
|
|
|
5.2 |
|
|
$ |
636,156 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable at December 31, 2020 |
|
|
369,361 |
|
|
$ |
1.35 |
|
|
$ |
3.80 |
|
|
|
5.2 |
|
|
$ |
636,156 |
|
|
| |
|
Number of Shares |
|
|
Weighted Average Exercise Price (USD) |
|
|
Weighted Average Grant Date Fair Value (USD) |
|
|
Weighted Average Remaining Contractual Term (years) |
|
|
Aggregate Intrinsic Value (USD) |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Outstanding – January 1, 2019 |
|
|
689,832 |
|
|
$ |
1.94 |
|
|
$ |
1.94 |
|
|
|
|
|
|
|
|
|
| Granted |
|
|
448,713 |
|
|
$ |
1.99 |
|
|
$ |
1.49 |
|
|
|
|
|
|
|
|
|
| Expired, forfeited, or cancelled |
|
|
(341,172 |
) |
|
$ |
1.99 |
|
|
$ |
0.36 |
|
|
|
|
|
|
|
|
|
| Outstanding – December 31, 2019 |
|
|
797,373 |
|
|
$ |
1.99 |
|
|
$ |
0.72 |
|
|
|
|
|
|
|
|
|
| Granted |
|
|
378,800 |
|
|
$ |
0.94 |
|
|
$ |
5.22 |
|
|
|
|
|
|
|
|
|
| Expired forfeited, or cancelled |
|
|
(246,408 |
) |
|
$ |
1.94 |
|
|
$ |
0.88 |
|
|
|
|
|
|
|
|
|
| Outstanding – December 31, 2020 |
|
|
929,765 |
|
|
$ |
1.53 |
|
|
$ |
2.50 |
|
|
|
6.1 |
|
|
$ |
2,537,245 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable at December 31, 2020 |
|
|
929,765 |
|
|
$ |
1.53 |
|
|
$ |
2.50 |
|
|
|
6.1 |
|
|
$ |
2,537,245 |
|
|
| Schedule of Fair Value Assumption of Stock Option |
|
The Company utilized the Black-Scholes option-pricing
model to determine the fair value of these stock options, using the assumptions as outlined below.
| Stock Price |
|
$ |
5.92 |
|
| Dividend Yield |
|
|
0 |
% |
| Expected Volatility |
|
|
84.7 |
% |
| Weighted Average Risk-Free Interest Rate |
|
|
0.37 |
% |
| Expected life (in years) |
|
|
1.5 – 4.2 |
|
|
| Schedule of Warrants |
The following table summarizes information about shares
issuable under warrants outstanding at March 31, 2021:
| |
|
Warrant
shares
outstanding |
|
|
Weighted
average
exercise price (USD) |
|
|
Weighted average remaining life |
|
|
Intrinsic value |
|
| Outstanding at January 1, 2021 |
|
|
3,661,178 |
|
|
$ |
1.98 |
|
|
|
|
|
|
|
|
|
| Issued |
|
|
3,535,519 |
|
|
$ |
4.93 |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
(851,099 |
) |
|
$ |
4.17 |
|
|
|
|
|
|
|
|
|
| Outstanding at March 31, 2021 |
|
|
6,345,598 |
|
|
$ |
3.33 |
|
|
|
4.9 |
|
|
$ |
6,049,152 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable at March 31, 2021 |
|
|
6,345,598 |
|
|
$ |
3.33 |
|
|
|
4.9 |
|
|
$ |
6,049,152 |
|
|
The following table summarizes information
about shares issuable under warrants outstanding at December 31, 2020:
| |
|
Warrant
shares
outstanding |
|
|
Weighted
average
exercise price (USD) |
|
|
Weighted average remaining life |
|
|
Intrinsic value |
|
| Outstanding at January 1, 2019 |
|
|
219,510 |
|
|
$ |
2.95 |
|
|
|
0.08 |
|
|
|
|
|
| Issued |
|
|
84,381 |
|
|
$ |
3.21 |
|
|
|
|
|
|
|
|
|
| Outstanding at December 31, 2019 |
|
|
303,891 |
|
|
$ |
3.02 |
|
|
|
1.06 |
|
|
$ |
- |
|
| Issued |
|
|
3,222,331 |
|
|
$ |
1.96 |
|
|
|
|
|
|
|
|
|
| Forfeited |
|
|
(274,816 |
) |
|
$ |
(3.00 |
) |
|
|
|
|
|
|
|
|
| Outstanding at December 31, 2020 |
|
|
3,251,406 |
|
|
$ |
1.95 |
|
|
|
4.97 |
|
|
$ |
- |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercisable at December 31, 2020 |
|
|
3,251,406 |
|
|
$ |
1.95 |
|
|
|
4.97 |
|
|
$ |
8,040,545 |
|
|
| Restricted Stock Awards [Member] |
|
|
| Schedule of Restricted Stock Units and Awards Activity |
The Company’s activity in restricted common
stock was as follows for the three months ended March 31, 2021:
| |
|
Number of
shares |
|
|
Weighted
average
grant date
fair
value |
|
| Non–vested at January 1, 2021 |
|
|
- |
|
|
$ |
- |
|
| Granted |
|
|
70,986 |
|
|
$ |
4.16 |
|
| Vested |
|
|
(44,390 |
) |
|
$ |
4.49 |
|
| Non–vested at March 31, 2021 |
|
|
26,596 |
|
|
$ |
3.61 |
|
|
|
| Restricted Stock Units [Member] |
|
|
| Schedule of Restricted Stock Units and Awards Activity |
The Company’s activity in restricted stock units
was as follows for the three months ended March 31, 2021:
| |
|
Number of shares |
|
|
Weighted average
grant date fair
value |
|
| Non–vested at January 1, 2021 |
|
|
- |
|
|
$ |
- |
|
| Granted |
|
|
3,279,284 |
|
|
$ |
4.41 |
|
| Vested |
|
|
(1,207,825 |
) |
|
$ |
4.46 |
|
| Non–vested at March 31, 2021 |
|
|
2,071,459 |
|
|
$ |
4.38 |
|
|
|